Cardiology News: April 2021

WEBINAR - May 20, 2021:
Echocardiography for Aortic Stenosis in the TAVR Era

IAC (International Accreditation Commission)
WEBINAR with CEU Credit

Presenter: Enrique Garcia-Sayan, MD, FACC, FASE

Date: May 20, 2021
Time:
02:00 PM - 03:00 PM Eastern(11:00 AM - 12:00 PM Pacific)
Subject:
Echocardiography for Aortic Stenosis in the TAVR Era

IAC Echocardiography will present a live webinar (followed by a Q&A session) entitled Echocardiography for Aortic Stenosis in the TAVR Era. This webinar is a joint presentation of IAC and ASE. In addition, registered participants will receive 1 contact hour of ASE CEU credit.

Repeated Mechanical Endovascular Thrombectomy for Recurrent Large Vessel Occlusion

29 April, 2021 - AHA Journal (American Heart Association)
 
Research Article
Background and Purpose:
Mechanical thrombectomy (MT) is now the standard of care for large vessel occlusion (LVO) stroke. However, little is known about the frequency and outcomes of repeat MT (rMT) for patients with recurrent LVO.

Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack

27 April, 2021 - AHA Journal (American Heart Association)
 
Research Article
Background and Purpose:
Antiplatelet therapy is key for preventing thrombotic events after transient ischemic attack or ischemic stroke. Although the role of aspirin is well established, there is emerging evidence for the role of short-term dual antiplatelet therapy (DAPT) in preventing recurrent stroke.;

Myocardial Histopathology in Patients with Obstructive Hypertrophic Cardiomyopathy

26 April, 2021 - JACC (Journal of the American College of Cardiology) Podcast
 
Podcast Background:
Hypertrophic cardiomyopathy (HCM) is characterized by multiple pathological features including myocyte hypertrophy, myocyte disarray, and interstitial fibrosis.

Objectives:
This study sought to correlate myocardial histopathology with clinical characteristics of patients with obstructive HCM and post-operative outcomes following septal myectomy.

Prospective ARNI vs. ACE inhibitor trial to Determine Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics

12 April, 2021 - NIH - National Library of Medicine
 
Research Article:
 
Aims: Patients surviving an acute myocardial infarction (AMI) are at risk of developing symptomatic heart failure (HF) or premature death. We hypothesized that sacubitril/valsartan, effective in the treatment of chronic HF, prevents the development of HF and reduces cardiovascular death following high-risk AMI compared to a proven angiotensin-converting enzyme (ACE) inhibitor. This paper describes the study design and baseline characteristics of patients enrolled in the Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI) trial.

Reducing Implicit Bias in the Admissions Process

Mayo Clinic College of Medicine & Science: Take 5 Video

A timely and helpful video reminder with a PDF checklist that we can use to reduce bias in our admissions processes.
 
Dr. Quinn Capers IV, an interventional cardiologist, medical educator, and Vice Dean for Faculty Affairs at The Ohio State University College of Medicine shares strategies his school's admissions office incorporated to recognize implicit bias and increase the diversity of healthcare teams.

DMS Cardiovascular news is a curated collection of articles, posts & studies related to general & interventional cardiology, cardiovascular & heart health that I found interesting and may be of help or interest to others. All articles are published on reliable and respected sources cited with links to read the original full article. 

Do you have questions about a medical case or need help understanding treatment plans and options?

Health & Patient Advocacy | Medical Case Review

Medical Expert Witness

Dalawari Medical Services - Medical Consulting

Click here to Contact Us via email  or  Call + (804)-500-0685

About Jasdeep Dalawari MD

Experienced General and Specialist Physician with a demonstrated history of working in the medical practice industry. Skilled in Interventional, Endovascular, Vascular, and General Cardiovascular Medicine; Emergency Medicine; Healthcare Consulting, including Peer Review, Expert Witness, and Utilization Review; and Medical Education. Strong healthcare services professional with an MS focused in Health Administration from Virginia Commonwealth University.

Leave a Comment